Regulus Therapeutics (RGLS)
(Delayed Data from NSDQ)
$1.76 USD
+0.01 (0.57%)
Updated Jul 25, 2024 04:00 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Earnings News For RGLS
-
Regulus: Q1 Earnings Snapshot
-
Regulus Therapeutics Reports First Quarter 2024 Financial Results and Recent Updates
-
Regulus: Q4 Earnings Snapshot
-
Regulus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Updates
-
Regulus: Q3 Earnings Snapshot
-
Regulus Therapeutics Reports Third Quarter 2023 Financial Results and Recent Updates
-
Regulus: Q2 Earnings Snapshot
-
Regulus Therapeutics Reports Second Quarter 2023 Financial Results and Recent Updates
-
Regulus: Q1 Earnings Snapshot
-
Regulus Therapeutics Reports First Quarter 2023 Financial Results and Recent Updates
-
Regulus: Q4 Earnings Snapshot
-
Regulus Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Updates
-
Regulus: Q3 Earnings Snapshot
-
Regulus Therapeutics Reports Third Quarter 2022 Financial Results and Recent Updates
-
Regulus: Q2 Earnings Snapshot
-
Regulus Therapeutics Reports Second Quarter 2022 Financial Results and Recent Updates
-
Regulus (RGLS) Reports Q3 Loss, Lags Revenue Estimates
-
Analysts Estimate Regulus (RGLS) to Report a Decline in Earnings: What to Look Out for
-
Regulus (RGLS) Reports Q2 Loss, Misses Revenue Estimates
-
Regulus (RGLS) Reports Q1 Loss, Misses Revenue Estimates
-
Regulus (RGLS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
Will Regulus (RGLS) Report Negative Q4 Earnings? What You Should Know
-
Regulus (RGLS) Reports Q3 Loss, Tops Revenue Estimates
-
Regulus (RGLS) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
Regulus (RGLS) Reports Q2 Loss, Lags Revenue Estimates